Status and phase
Conditions
Treatments
About
The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria(main):
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
Loading...
Central trial contact
Yehudit Kraizer, Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal